Plasmid-mediated quinolone resistance in isolates obtained in german intensive care units.

PubWeight™: 1.63‹?› | Rank: Top 4%

🔗 View Article (PMC 547280)

Published in Antimicrob Agents Chemother on February 01, 2005

Authors

Daniel Jonas1, Klaus Biehler, Doris Hartung, Bettina Spitzmüller, Franz D Daschner

Author Affiliations

1: Institute of Environmental Medicine and Hospital Epidemiology, University Hospital Freiburg, Hugstetter Str. 55, D-79106 Freiburg, Germany. djonas@IUK3.UKL.uni-Freiburg.de

Articles citing this

ISCR elements: novel gene-capturing systems of the 21st century? Microbiol Mol Biol Rev (2006) 5.50

Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev (2009) 4.43

New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob Agents Chemother (2007) 3.33

Origin of plasmid-mediated quinolone resistance determinant QnrA. Antimicrob Agents Chemother (2005) 3.18

Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital. Antimicrob Agents Chemother (2007) 1.97

Complete nucleotide sequence of pK245, a 98-kilobase plasmid conferring quinolone resistance and extended-spectrum-beta-lactamase activity in a clinical Klebsiella pneumoniae isolate. Antimicrob Agents Chemother (2006) 1.76

Quinolones: action and resistance updated. Curr Top Med Chem (2009) 1.73

Pentapeptide repeat proteins. Biochemistry (2006) 1.68

Broader distribution of plasmid-mediated quinolone resistance in the United States. Antimicrob Agents Chemother (2005) 1.60

Association of plasmid-mediated quinolone resistance with extended-spectrum beta-lactamase VEB-1. Antimicrob Agents Chemother (2005) 1.53

Enterobacter cloacae outbreak and emergence of quinolone resistance gene in Dutch hospital. Emerg Infect Dis (2006) 1.31

First outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in Germany. Eur J Clin Microbiol Infect Dis (2010) 1.29

Vibrio parahaemolyticus chromosomal qnr homologue VPA0095: demonstration by transformation with a mutated gene of its potential to reduce quinolone susceptibility in Escherichia coli. Antimicrob Agents Chemother (2005) 1.28

High-level ciprofloxacin resistance from point mutations in gyrA and parC confined to global hospital-adapted clonal lineage CC17 of Enterococcus faecium. J Clin Microbiol (2006) 1.17

Mechanism of action of and resistance to quinolones. Microb Biotechnol (2008) 1.16

Plasmid-mediated quinolone resistance. Microbiol Spectr (2014) 1.13

Presence of qnr gene in Escherichia coli and Klebsiella pneumoniae resistant to ciprofloxacin isolated from pediatric patients in China. BMC Infect Dis (2008) 1.02

Mechanisms of drug resistance: quinolone resistance. Ann N Y Acad Sci (2015) 1.00

qnr Prevalence in Extended Spectrum Beta-lactamases (ESBLs) and None-ESBLs Producing Escherichia coli Isolated from Urinary Tract Infections in Central of Iran. Iran J Basic Med Sci (2011) 0.91

Prevalence of plasmid-mediated quinolone resistance and its association with extended-spectrum beta-lactamase and AmpC beta-lactamase in Enterobacteriaceae. Korean J Lab Med (2011) 0.89

Fluoroquinolone resistance linked to both gyrA and parC mutations in the quinolone resistance-determining region of Shigella dysenteriae type 1. Curr Microbiol (2006) 0.86

Emergence of plasmid-mediated quinolone-resistant determinants in Klebsiella pneumoniae isolates from Tehran and Qazvin provinces, Iran. J Prev Med Hyg (2015) 0.77

Articles cited by this

Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 665.31

PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother (1995) 12.54

Identification of the uncultured bacillus of Whipple's disease. N Engl J Med (1992) 12.33

Quinolone resistance from a transferable plasmid. Lancet (1998) 11.28

DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev (1997) 9.69

Mechanism of plasmid-mediated quinolone resistance. Proc Natl Acad Sci U S A (2002) 7.76

Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother (2003) 6.26

Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin Microbiol Rev (1996) 6.12

Prevalence of plasmid-mediated quinolone resistance. Antimicrob Agents Chemother (2003) 4.29

Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrob Agents Chemother (2004) 3.54

Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria. Antimicrob Agents Chemother (2000) 3.22

Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds. J Antimicrob Chemother (1998) 3.21

Interaction of plasmid and host quinolone resistance. J Antimicrob Chemother (2003) 3.13

Detection of the plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumoniae producing AmpC-type beta-lactamase. J Antimicrob Chemother (2003) 2.37

DNA sequence of direct repeats of the sulI gene of plasmid pSa. Plasmid (1994) 2.00

Design of a surveillance system of antibiotic use and bacterial resistance in German intensive care units (SARI). Infection (2003) 1.77

Molecular epidemiological study of nosocomial Enterobacter aerogenes isolates in a Belgian hospital. J Clin Microbiol (1998) 1.19

Anaerobic nitrogen-fixing consortia consisting of clostridia isolated from gramineous plants. Appl Environ Microbiol (2004) 1.17

Articles by these authors

A Stenotrophomonas maltophilia multilocus sequence typing scheme for inferring population structure. J Bacteriol (2009) 1.44

Discrimination of Klebsiella pneumoniae and Klebsiella oxytoca phylogenetic groups and other Klebsiella species by use of amplified fragment length polymorphism. Res Microbiol (2004) 1.30

Does disinfection of environmental surfaces influence nosocomial infection rates? A systematic review. Am J Infect Control (2004) 0.93

Surveillance of antimicrobial use and antimicrobial resistance in intensive care units (SARI): 1. Antimicrobial use in German intensive care units. Intensive Care Med (2004) 0.93

Lack of the small plastid-encoded PsbJ polypeptide results in a defective water-splitting apparatus of photosystem II, reduced photosystem I levels, and hypersensitivity to light. J Biol Chem (2002) 0.91

Modified guidelines impact on antibiotic use and costs: duration of treatment for pneumonia in a neurosurgical ICU is reduced. J Antimicrob Chemother (2007) 0.90

Visualization of initial bacterial colonization on dentine and enamel in situ. J Microbiol Methods (2010) 0.88

Food-borne enterococci integrate into oral biofilm: an in vivo study. J Endod (2010) 0.88

Methicillin-resistant Staphylococcus aureus in German intensive care units during 2000-2003: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in Intensive Care Units). Infect Control Hosp Epidemiol (2006) 0.86

Extract of Pelargonium sidoides (EPs 7630) improves phagocytosis, oxidative burst, and intracellular killing of human peripheral blood phagocytes in vitro. Phytomedicine (2006) 0.83

Development and mechanism of fluoroquinolone resistance in Legionella pneumophila. J Antimicrob Chemother (2003) 0.82

Bacterial and Candida albicans adhesion on different root canal filling materials and sealers. J Endod (2011) 0.81

Detection and activity of peroxidase in the in situ formed enamel pellicle. Arch Oral Biol (2008) 0.80

Polyphenolic beverages reduce initial bacterial adherence to enamel in situ. J Dent (2009) 0.80

Extract of Pelargonium sidoides (EPs 7630) inhibits the interactions of group A-streptococci and host epithelia in vitro. Phytomedicine (2006) 0.80

Targeted immobilisation of lysozyme in the enamel pellicle from different solutions. Clin Oral Investig (2009) 0.78

Effects of Cistus-tea on bacterial colonization and enzyme activities of the in situ pellicle. J Dent (2008) 0.77

Characterisation of lysozyme activity in the in situ pellicle using a fluorimetric assay. Clin Oral Investig (2008) 0.76

Ceftriaxone versus other cephalosporins for perioperative antibiotic prophylaxis: a meta-analysis of 43 randomized controlled trials. Chemotherapy (2002) 0.76

Persistent silver disinfectant for the environment: myth and reality. Am J Infect Control (2004) 0.75

Flow cytometric measurements of neutrophil functions: the dependence on the stimulus to cell ratio. FEMS Immunol Med Microbiol (2003) 0.75

Pathogen growth in herbal teas used in clinical settings: a possible source of nosocomial infection? Am J Infect Control (2004) 0.75